Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR3 | P51677 | 6/20 | 0.64 |
| ▸ | HTR1A | P08908 | 1/20 | 0.63 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | EED | O75530 | 1/20 | 0.53 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8634509 | 0.88 | CCR3 (0.59) | CCR3HTR1ASLC6A4MEN1KMT2A | |
| SCHEMBL8636409 | 0.84 | KDM4E (0.61) | CCR3HTR1ASLC6A4MEN1KMT2A | |
| SCHEMBL4239734 | 0.82 | CCR3 (0.54) | CCR3HTR1ASLC6A4MEN1KMT2A | |
| SCHEMBL8636890 | 0.82 | HTR1A (0.56) | CCR3HTR1ASLC6A4MEN1KMT2A | |
| SCHEMBL7362108 | 0.82 | FAAH (0.72) | MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL16825188 | 0.81 | TGFBR1 (0.56) | CCR3HTR1ASLC6A4MEN1KMT2A | |
| SCHEMBL27233570 | 0.81 | EPHX2 (0.71) | CCR3HTR1ASLC6A4MEN1KMT2A | |
| SCHEMBL12466446 | 0.80 | MEN1 (0.56) | CCR3HTR1ASLC6A4MEN1KMT2A | |
| SCHEMBL27004162 | 0.80 | FAAH (0.60) | CCR3 | |
| SCHEMBL14421472 | 0.79 | HTR1A (0.71) | HTR1ASLC6A4EED |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0718286-B1 | 3-Alkoxybenzylpiperidine derivatives as melatonergic agents | BRISTOL MYERS SQUIBB CO (US) | 1998-07-29 | — | — | EP | claimed |
| EP-0718286-A1 | 3-Alkoxybenzylpiperidine derivatives as melatonergic agents | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-06-26 | — | — | EP | claimed |
| US-5530012-A | FOR SLEEP DISORDERS, DEPRESSION, GLAUCOMA, CANCER | BRISTOL-MYERS SQUIBB CO. (US) | 1996-06-25 | — | — | US | claimed |
| EP-0718286-B1 | 3-Alkoxybenzylpiperidine derivatives as melatonergic agents | BRISTOL MYERS SQUIBB CO (US) | 1998-07-29 | — | — | EP | disclosed |
| EP-0718286-A1 | 3-Alkoxybenzylpiperidine derivatives as melatonergic agents | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-06-26 | — | — | EP | disclosed |
| US-5530012-A | FOR SLEEP DISORDERS, DEPRESSION, GLAUCOMA, CANCER | BRISTOL-MYERS SQUIBB CO. (US) | 1996-06-25 | — | — | US | disclosed |